Ursolic Acid and Rutin Isolated from <i>Biophytum umbraculum</i>: Antiproliferative Activity of the Plant Against Human Adherent Cancer Cell Lines

In recent years, <i>Biophytum umbraculum</i> Welw. (Oxalidaceae) has undergone several phytochemical and pharmacological investigations. Although its major phytochemical classes have been characterized, few isolated compounds have been reported. The previously detected phytoconstituents, along with the documented antioxidant and anti-inflammatory activities, both align with a potential antiproliferative effect. This study aims to complement the existing chemotaxonomic profile of <i>B. umbraculum</i> through the isolation and identification of phytoconstituents and to evaluate the antiproliferative potential of its extracts. Hexane, ethyl acetate, and methanolic extracts of <i>B. umbraculum</i> were screened against two human adherent cell lines, breast (MCF-7) and cervical (SiSo) adenocarcinomas, by using the crystal violet staining assay. The hexane extract inhibited both MCF-7 and SiSo cell proliferation with IC₅₀ values of 8.93 ± 0.07 and 14.59 ± 0.08 µg/mL, respectively. The ethyl acetate extract showed activity against both cell lines, with IC₅₀ values of 12.60 ± 0.14 and 13.10 ± 0.04 µg/mL, respectively. However, the methanolic extract was inactive on the MCF-7 cell line and only slightly active on the SiSo cell line. Chromatographic fractionations led to the isolation of ursolic acid from the active ethyl acetate extract and rutin from the methanolic extract. A further antiproliferative evaluation is warranted to confirm the contribution of ursolic acid to the effect of the ethyl acetate extract. Additional fractionations may uncover more phytoconstituents of diverse pharmaceutical interests.